Evidence map›Paper›PMID 25297854›Full record

ArticleClinical chemistry2015

Single-tube, highly parallel mutation enrichment in cancer gene panels by use of temperature-tolerant COLD-PCR.

Elena Castellanos-Rizaldos, Katherine Richardson, Rui Lin, Grant Wu, Mike G Makrigiorgos

Open access · bronzeAbstract read
In one paragraph

Article in Clinical chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Elena Castellanos-RizaldosDivision of DNA Repair and Genome Stability and.
Katherine RichardsonTransgenomic Inc., Omaha, NE.
Rui LinTransgenomic Inc., Omaha, NE.
Grant WuTransgenomic Inc., Omaha, NE.
Mike G MakrigiorgosDivision of DNA Repair and Genome Stability and Division of Medical Physics and Biophysics, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; mmakrigiorgos@lroc.harvard.edu.
Transgenomic (United States) · USHarvard University · US

Funding

Prognostic potential of low-level mutations in meylodysplastic syndromeR21CA175542 · NCI · DANA-FARBER CANCER INST · PI MAKRIGIORGOS, G. MIKE · 2014 to 2015
$419k
Temperature-Tolerant COLD-PCR enables mutation-enriched targeted re-sequencingR41CA180389 · NCI · TRANSGENOMIC, INC. · PI MAKRIGIORGOS, G. MIKE, RICHARDSON, KATHERINE ANNE · 2013 to 2013
$200k
NCI NIH HHS 1 R21 CA175542-01A1NCI NIH HHS 1 R41 CA180389-01NCI NIH HHS R21 CA175542NCI NIH HHS R41 CA180389NCI NIH HHS R41 CA180389-01
6 · The paper itself

Abstract

backgroundMultiplexed detection of low-level mutations presents a technical challenge for many technologies, including cancer gene panels used for targeted-resequencing. Analysis of mutations below approximately 2%-5% abundance in tumors with heterogeneity, samples with stromal contamination, or biofluids is problematic owing to increased noise from sequencing errors. Technologies that reduce noise via deep sequencing unavoidably reduce throughput and increase cost. Here we provide proof of principle that coamplification at lower denaturation temperature (COLD)-PCR technology enables multiplex low-level mutation detection in cancer gene panels while retaining throughput.

methodsWe have developed a multiplex temperature-tolerant COLD-PCR (fast-TT-COLD-PCR) approach that uses cancer gene panels developed for massively parallel sequencing. After multiplex preamplification from genomic DNA, we attach tails to all amplicons and perform fast-TT-COLD-PCR. This approach gradually increases denaturation temperatures in a step-wise fashion, such that all possible denaturation temperatures are encompassed. By introducing modified nucleotides, fast-COLD-PCR is adapted to enrich for melting temperature (Tm)-increasing mutations over all amplicons, in a single tube. Therefore, in separate reactions, both Tm-decreasing and Tm-increasing mutations are enriched.

resultsUsing custom-made and commercial gene panels containing 8, 50, 190, or 16 000 amplicons, we demonstrate that fast-TT-COLD-PCR enriches mutations on all examined targets simultaneously. Incorporation of deoxyinosine triphosphate (dITP)/2,6-diaminopurine triphosphate (dDTP) in place of deoxyguanosine triphosphate (dGTP)/deoxyadenosine triphosphate (dATP) enables enrichment of Tm-increasing mutations. Serial dilution experiments demonstrate a limit of detection of approximately 0.01%-0.1% mutation abundance by use of Ion-Torrent and 0.1%-0.3% by use of Sanger sequencing.

conclusionsFast-TT-COLD-PCR improves the limit of detection of cancer gene panels by enabling mutation enrichment in multiplex, single-tube reactions. This novel adaptation of COLD-PCR converts subclonal mutations to clonal, thereby facilitating detection and subsequent mutation sequencing.

Indexed as

Genes, NeoplasmMutationCell LineDNAHigh-Throughput Nucleotide SequencingHumansLimit of DetectionMultiplex Polymerase Chain ReactionNeoplasmsReproducibility of ResultsDNA

Identifiers

PMID25297854
PMCPMC4281501
OpenAlexW2148709465

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.